Syed Zohad Shah: Reducing Blood Loss and Hospital Stays in Non-Cardiac Thoracic Surgery
Syed Zohad Shah, Peer Reviewer at Springer Nature, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in The Cardiothoracic Surgeon, adding:
“Excited to share our recently published systematic review and meta-analysis.
‘Optimizing hemostasis in thoracic surgery: a systematic review and meta-analysis of perioperative antifibrinolytic therapy.’
This study evaluated the efficacy and safety of perioperative antifibrinolytic therapy—including tranexamic acid (TXA) and aprotinin—in adult patients undergoing non-cardiac thoracic surgery.
Across 15 studies involving 2,169 patients, our analysis found that antifibrinolytic therapy was associated with:
- Reduced 24-hour postoperative blood loss
- Reduced total red blood cell transfusion volume
- Shorter hospital stay
- Consistent benefits in sensitivity analyses, including major thoracic procedures
- No significant increase in respiratory complications or reoperation for bleeding
The study also explored differences between intravenous and topical administration and between TXA and aprotinin, providing additional insight into perioperative blood conservation strategies.
I’m grateful to have contributed to this work through data extraction, data analysis, and interpretation of results, and to have worked alongside an excellent multidisciplinary team of researchers and clinicians.
Open Access Publication
Published in: The Cardiothoracic Surgeon (2026)
Research like this reinforces the importance of evidence-based approaches to improving perioperative outcomes and optimizing patient care.”
Title: Optimizing hemostasis in thoracic surgery: a systematic review and meta-analysis of perioperative antifibrinolytic therapy
Authors: Muhammad Hamza, Zohad Shah, Hasnain Wajeeh Saqib, Syeda Rabiah Shahid, Muhammad Murad Khurshid, Sheza Irfan, Aizaz Anwar Khalid, Arshdeep Singh, Ikram Ul Haq Chaudhry, Asif Raza Shah
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question